Abstract
Background: Very long chain acyl CoA dehydrogenase (VLCAD) deficiency (OMIM#201475) is an autosomal recessive disorder of fatty acid beta oxidation caused by defect in the ACADVL. The aim of this study was to analyze the clinical, biochemical, and molecular features of VLCAD deficiency in Saudi Arabia, including the treatment and outcome.
Methods: We carried out a retrospective chart review analysis of 37 VLCAD deficiency patients from two tertiary centers in Saudi Arabia, over a 14-year period (2002–2016). Twenty-three patients were managed at King Abdul-Aziz Medical City and fourteen patients at King Fahad Medical City.
Results: Severe early onset VLCAD deficiency is the most frequent phenotype in our patients, caused by four different mutations in ACADVL; 31 patients (83.7%) had a homozygous nonsense mutation in exon 2 of ACADVL c.65C>A;p. Ser22X. Twenty-three patients died before the age of 2 years, despite early detection by newborn screening and implementation of treatment, including supplementation with medium chain triglycerides.
Conclusion: This study reports the clinical, biochemical, molecular findings, treatment, and outcome of patients with VLCAD deficiency over the last 14 years. We identified the most common variant and one new variant in ACADVL. Despite early diagnosis and treatment, the outcome of VLCAD deficiency in this Saudi Arabian population remains poor. Preventive measures, such as prenatal diagnosis, could be implemented.
References
Alfadhel M, Benmeakel M, Hossain MA et al (2016) Thirteen year retrospective review of the spectrum of inborn errors of metabolism presenting in a tertiary center in Saudi Arabia. Orphanet J Rare Dis 11:126
Al-Gazali L, Hamamy H, Al-Arrayad S (2006) Genetic disorders in the Arab world. BMJ 333:831–834
Al-Owain M, Al-Zaidan H, Al-Hassnan Z (2012) Map of autosomal recessive genetic disorders in Saudi Arabia: concepts and future directions. Am J Med Genet A 158A:2629–2640
Andresen BS, Olpin S, Poorthuis BJ et al (1999) Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet 64:479–494
Aoyama T, Uchida Y, Kelley RI et al (1993) A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. Biochem Biophys Res Commun 191:1369–1372
Aoyama T, Souri M, Ueno I et al (1995) Cloning of human very-long-chain acyl-coenzyme a dehydrogenase and molecular characterization of its deficiency in two patients. Am J Hum Genet 57:273–283
Bonnet D, Martin D, De Pascale L et al (1999) Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 100:2248–2253
Chace DH, Kalas TA, Naylor EW (2002) The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annu Rev Genomics Hum Genet 3:17–45
Christianson A, Howson CP, Modell B (2006) March of Dimes global report on birth defects: the hidden toll of dying and disabled children. In: March of Dimes global report on birth defects: the hidden toll of dying and disabled children. March of Dimes Birth Defects Foundation, White Plains, p 76
Diekman EF, Ferdinandusse S, van der Pol L et al (2015) Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency. Genet Med 17:989–994
Evans M, Andresen BS, Nation J, Boneh A (2016) VLCAD deficiency: follow-up and outcome of patients diagnosed through newborn screening in Victoria. Mol Genet Metab 118:282–287
Fukao T, Watanabe H, Orii K et al (2001) Myopathic form of very-long chain acyl-CoA dehydrogenase deficiency: evidence for temperature-sensitive mild mutations in both mutant alleles in a Japanese girl. Pediatr Res 49:227–231
Gelinas R, Thompson-Legault J, Bouchard B et al (2011) Prolonged QT interval and lipid alterations beyond beta-oxidation in very long-chain acyl CoA dehydrogenase null mouse hearts. Am J Physiol Heart Circ Physiol 301:H813–H823
Hale DE, Batshaw ML, Coates PM et al (1985) Long-chain acyl coenzyme a dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatr Res 19:666–671
Leslie ND, Valencia CA, Strauss AW, Connor JA, Zhang K (1993) Very long-chain acyl-coenzyme A dehydrogenase deficiency. In: Pagon RA, Adam MP, Ardinger HH et al (eds) GeneReviews®. University of Washington, Seattle, Seattle
McHugh D, Cameron CA, Abdenur JE et al (2011) Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med 13:230–254
Miller MJ, Burrage LC, Gibson JB et al (2015) Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl CoA dehydrogenase (VLCAD) deficiency in the United States. Mol Genet Metab 116:139–145
Ogilvie I, Pourfarzam M, Jackson S, Stockdale C, Bartlett K, Turnbull DM (1994) Very long-chain acyl coenzyme a dehydrogenase deficiency presenting with exercise-induced myoglobinuria. Neurology 44:467–473
Spiekerkoetter U (2010) Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening. J Inherit Metab Dis 33:527–532
Spiekerkoetter U, Tenenbaum T, Heusch A, Wendel U (2003) Cardiomyopathy and pericardial effusion in infancy point to a fatty acid b-oxidation defect after exclusion of an underlying infection. Pediatr Cardiol 24:295–297
Touma EH, Rashed MS, Vianey-Saban C et al (2001) A severe genotype with favourable outcome in very long chain acyl CoA dehydrogenase deficiency. Arch Dis Child 84:58–60
Vockley J, Whiteman DA (2002) Defects of mitochondrial beta-oxidation: a growing group of disorders. Neuromuscul Disord 12:235–246
Watanabe H, Orii KE, Fukao T et al (2000) Molecular basis of very long chain acyl CoA dehydrogenase deficiency in three Israeli patients: identification of a complex mutant allele with P65L and K247Q mutations, the former being an exonic mutation causing exon 3 skipping. Hum Mutat 15:430–438
Yamamoto A, Nakamura K, Matsumoto S et al (2013) VLCAD deficiency in a patient who recovered from ventricular fibrillation, but died suddenly of a respiratory syncytial virus infection. Pediatr Int 55:775–778
Zytkovicz TH, Fitzgerald EF, Marsden D et al (2001) Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 47:1945–1955
Acknowledgments
The authors would like to thank the patients and their families. The authors would also like to extend their acknowledgment to Ms. Rasha Al-kindi for her support in data collection.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Verena Peters
Appendices
Learning Point
Truncating null mutations was the most common genotype in our VLCAD deficiency patients, with poor outcome despite early diagnosis and proper management. Prenatal diagnosis be a preferable strategy for managing this disorder in our population.
Details of the Contributions of Individual Authors
AO: performed the majority of work associated with preparing, writing, and submitting the manuscript and contributed to the clinical diagnosis and management of the patient. MN: performed work associated with preparing, writing, and intellectual discussion. MF, AAS, and FM: contributed to the diagnosis and management of the patient at KAMC and edited the manuscript. AAA, EF, and AM: contributed to the clinical diagnosis and management of the patient at KFMC and edited the manuscript. DM: Study design, manuscript writing, and final revision. MAB and MAA: Data collection and manuscript revision. WE: contributed to the clinical diagnosis and management of the patient and performed the work related to study design, conceptual discussion, and manuscript writing and revision. All authors read and approved the final manuscript.
Guarantor Author
Wafaa Eyaid.
Compliance with Ethics Guidelines
Conflict of Interest
Abdulrahman Obaid, Marwan Nashabat, Majid Alfadhel, Ali Alasmari, Fuad Al Mutairi, Abdulrahman Alswaid, Eissa Faqeih, Aziza Mushiba, Deborah Marsden, Marwah Albanyan, Maryam Alalwan, and Wafaa Eyaid declare that they have no conflict of interest.
Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all parents and available upon request.
Details of Ethics Approval
This study was approved by King Abdullah International Medical Research Center IRB (RC16/189/R).
Details of Funding
This study received no specific funding from any financial support agency either public or commercial and not-for-profit sectors.
Rights and permissions
Copyright information
© 2017 Society for the Study of Inborn Errors of Metabolism (SSIEM)
About this chapter
Cite this chapter
Obaid, A. et al. (2017). Clinical, Biochemical, and Molecular Features in 37 Saudi Patients with Very Long Chain Acyl CoA Dehydrogenase Deficiency. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 40. JIMD Reports, vol 40. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2017_58
Download citation
DOI: https://doi.org/10.1007/8904_2017_58
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-57879-7
Online ISBN: 978-3-662-57880-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)